Jommi C, Pippo L, Bortolami A et al. Il governo dell’assistenza farmaceutica in Italia: il ruolo di Stato e Regioni. Politiche sanitarie. Anno 2021, Vol. 22, N. 3: 117-124. https://www.dephaforum.it/wp-content/uploads/2023/02/Paper_Politiche_-Sanitarie.pdf (Accessed July 2023)

De Rosa M, Messori A, Scroccaro G. Il sistema dei prontuari in Italia 2. Aboutpharma Srl; 2010.

Prada M, Ruggeri M, Sansone C, et al. Timeline of authorization and reimbursement for oncology drugs in Italy in the last 3 years, Medicine Access @. Point Care. 2017;1(1):e29-e36. DOI: https://doi.org/10.5301/maapoc.0000007

Russo P, Mennini FS, Siviero PD, Rasi G. Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers. Ann Oncol. 2010;21(10):2081-2087. https://doi.org/10.1093/annonc/mdq097 PMID:20335370 DOI: https://doi.org/10.1093/annonc/mdq097

Mantuano M, Daniel F, Urbinati D. Regional time to market of innovative drugs in Italy. PHP70. Value Health. 2016;19(7):451. https://doi.org/10.1016/j.jval.2016.09.608 DOI: https://doi.org/10.1016/j.jval.2016.09.608

Pizzimenti V, Formica D, Sultana J, et al. Access of medicines to the market: three years’ experience of Sicily’s regional drug formulary. Gazz Med Ital- Arch Sci Med. 2020;179(5):317-325. https://doi.org/10.23736/S0393-3660.19.04030-0 DOI: https://doi.org/10.23736/S0393-3660.19.04030-0

Nicolucci A, Caputi A. Difformità regionali di accesso ai nuovi farmaci per il diabete a distribuzione territoriale. JAMD. 2021;24(4):257-263. https://doi.org/10.36171/Jamd21.24.4.3 DOI: https://doi.org/10.36171/jamd21.24.4.3

Jommi C, Costa E, Michelon A, Pisacane M, Scroccaro G. Multi-tier drugs assessment in a decentralised health care system. The Italian case-study. Health Policy. 2013;112(3):241-247. https://doi.org/10.1016/j.healthpol.2013.06.004 PMID:23850166 DOI: https://doi.org/10.1016/j.healthpol.2013.06.004

Prada M, Rossi L, Molchanova E, Mariano EE. Italian regional access for drugs: 20 regions vs 21 procedures. PNS59. Value Health. 2020;23:S653. https://doi.org/10.1016/j.jval.2020.08.1503 DOI: https://doi.org/10.1016/j.jval.2020.08.1503

Urbinati D, Cioni L, Tucci C. Centralization and complexity of drug market access process across Italian Regions. PHP157. Value Health. 2017;20(9):679. https://doi.org/10.1016/j.jval.2017.08.1689 DOI: https://doi.org/10.1016/j.jval.2017.08.1689

ISTAT. Popolazione residente al 1/1/2023 http://dati.istat.it/Index.aspx?DataSetCode=DCIS_POPRES1, (Accessed July 2023).